Browsing Tag

CorMedix

CorMedix Inc. Announces Regulatory and Manufacturing Updates

Eli Pacheco Aug 9, 2022 0

BERKELEY HEIGHTS, N.J., Aug. 08, 2022 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the…

Health

CorMedix Inc. Announces FDA Acceptance of Resubmission of New Drug Application for…

Eli Pacheco Mar 28, 2022 0

BERKELEY HEIGHTS, N.J., March 28, 2022 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the…

Health

Cormedix Inc. Announces Resubmission of New Drug Application for DefenCath

Eli Pacheco Feb 28, 2022 0

BERKELEY HEIGHTS, N.J., Feb. 28, 2022 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the…